| Recruitment status | |
| Unique ID issued by UMIN | UMIN000025679 |
| Receipt No. | R000029541 |
| Scientific Title | The evaluation for IFCR <intrauterine fiberscope and curettage of the endometrium> by a prospective randomized controlled trial |
| Date of disclosure of the study information | 2017/01/16 |
| Last modified on | 2021/05/02 (Ver. 2) |
| Basic information | ||
| Public title | The evaluation for IFCR <intrauterine fiberscope and curettage of the endometrium> by a prospective randomized controlled trial | |
| Acronym | The evaluation for IFCE by RCT | |
| Scientific Title | The evaluation for IFCR <intrauterine fiberscope and curettage of the endometrium> by a prospective randomized controlled trial | |
| Scientific Title:Acronym | The evaluation for IFCE by RCT | |
| Region |
|
|
| Condition | ||
| Condition | Infertile patients with repeated embryo implantation failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Does our technique with intrauterine fiberscope and curettage of the endometrium (IFCE) improves reproductive outcome for infertile patients with repeated embryo implantation failure ?
|
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Clinical pregnancy rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | IFCE group | ||
| Interventions/Control_2 | non-IFCE group | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Infertile patients with repeated embryo implantation failure.
2. Patients indicated to undergo a cycle of IVF/ICSI with their own oocytes. 3. Age <= 50 years. 4. BMI: 18.5 to 30. 5. Normal ovarian reserve (AFC >= 8; FSH < 8). 6. The most appropriate stimulation protocol will be decided by their doctor. 5. The most appropriate stimulation protocol will be decided by their doctor. |
|||
| Key exclusion criteria | 1. Patients with a severe male factor (spermatozoa < 2 million/ml).
|
|||
| Target sample size | 500 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Oak Clinic, Japan | ||||||
| Division name | IVF Center | ||||||
| Zip code | 557-0045 | ||||||
| Address | 2-7-9 Tamade-nishi, Nishinari, Osaka, JAPAN | ||||||
| TEL | 06-4398-1000 | ||||||
| funabiki_m@oakclinic-group.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Oak Clinic, Japan | ||||||
| Division name | IVF Center | ||||||
| Zip code | 557-0045 | ||||||
| Address | 2-7-9 Tamade-nishi, Nishinari, Osaka, Japan | ||||||
| TEL | 06-4398-1000 | ||||||
| Homepage URL | |||||||
| funabiki_m@oakclinic-group.com | |||||||
| Sponsor | |
| Institute | Oak Clinic, Japan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Oak Clinic, Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Oak Clinic Sumiyoshi, Japan |
| Address | 2-7-9, Tamadenishi, Nishinari-ku, Osaka-city, Japan |
| Tel | 0643981019 |
| oakclinic.irb@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | |||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029541 |